PlainRecalls
FDA Drug Moderate Class II Terminated

Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***

Reported: October 31, 2012 Initiated: August 7, 2012 #D-033-2013

Product Description

Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***

Reason for Recall

Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.

Details

Units Affected
24,331 bottles
Distribution
Nationwide.
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 24,331 bottles.
Why was this product recalled?
Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 31, 2012. Severity: Moderate. Recall number: D-033-2013.